Watson

  • Watson in talks to buy Actavis

    Watson Pharmaceuticals is currently in talks to buy private Swiss generic drug maker Actavis.

    Watson | 11 May 2012

  • Watson's rosuvastatin zinc tablets receive tentative FDA approval

    Watson Pharmaceuticals Inc announced that its subsidiary, Watson Laboratories Inc, has received tentative approval from the United States Food and Drug Administration (FDA) for its rosuvastatin zinc 5, 10, 20 and 40 mg tablets. Watson's rosuvastatin …

    Watson | 10 August 2011

  • Watson designates new corporate headquarters

    Watson Pharmaceuticals Inc announced that it has formally designated its Parsippany, New Jersey facility as its corporate headquarters. The new headquarters occupies an entire building within a multi-tenant corporate office campus as well as a fl…

    Watson | 14 April 2011

  • Watson announces approval of generic alternative for the treatment of iron deficiency anemia

    Watson Pharmaceuticals Inc announced that it is initiating launch activities of Nulecit (sodium ferric gluconate complex in sucrose injection), following FDA approval of GeneraMedix Inc's abbreviated new drug application (ANDA). Nulecit is said to be…

    Watson | 01 April 2011

  • Watson Laboratories launches generic Famvir

    Watson Pharmaceuticals Inc confirmed that its subsidiary, Watson Laboratories Inc has launched Famciclovir tablets, 125 mg, 250 mg and 500 mg, the generic version of Novartis' Famvir following approval of its Abbreviated New Drug Application (ANDA) b…

    Watson | 21 March 2011

  • Watson Receives Approval for Heart Failure Drug

    Watson Laboratories has received approval from the US Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for metoprolol succinate extended-release tablets USP in the 100 and 200 mg strengths, the generic equivalent to A…

    Watson | 22 April 2010

  • Watson to Divest Ownership in Taiwan Company

    Watson Pharmaceuticals has signed an agreement to divest its equity ownership position of approximately 31 percent of ScinoPharm Taiwan. The transaction is subject to the parties obtaining approvals from various government agencies in Taiwan, as …

    Watson | 18 March 2010

  • Watson Completes Acquisition of Eden Biopharm

    Watson Pharmaceuticals has completed the acquisition of Eden Biopharm Group for approximately US$15 million. The latter is a biopharmaceutical development and contract manufacturing company that is located in Liverpool, UK. As a result of the acq…

    Watson | 10 February 2010

  • Watson Appoints Vice Presidents

    Watson Pharmaceuticals has announced that Robert Stewart has joined the company in the position of Senior VP, Global Operations. In this position, Stewart will have responsibility for global manufacturing, supply chain, quality and technical operatio…

    Watson | 01 January 2010

  • Millipore Selects LIMS from Thermo Fisher

    Thermo Fisher Scientific has announced that Millipore has implemented the Watson Laboratory Information Management System (LIMS) within the latter’s Preclinical and Clinical Development Services group. The group will use the LIMS in its Regulat…

    Watson | 02 December 2009

Page 1 Next > Last >>